ABC01379US

Tenofovir impurity C

Tenofovir impurity C is a structurally related byproduct arising from the synthetic pathway of tenofovir disoproxil fumarate. It retains the core cyclopropyl-carbonyl-phosphonate scaffold but features an additional hydroxyl group on the terminal phosphate moiety, distinguishing it from the parent compound. This impurity results from incomplete esterification during phosphonate prodrug synthesis, leading to a partially hydrolyzed phosphate ester. Its unique functional groups include a free primary amine, a furanose-like cyclic structure, and a zwitterionic phosphate center. The compound exhibits distinct chromatographic properties due to its altered hydrophilicity and ionic character. It serves as a critical HPLC reference standard for quantifying process-related impurities in tenofovir drug substance assays.

On Request
Molecular Formula C22H32N5O14P
Molecular Weight 621.5000
CAS Number 1798422-29-3 โœ“ Verified
Purity N/A
Product Type API Impurity
Parent Drug Tenofovir
Lead Time On Request
IUPAC Name [2-(6-aminopurin-9-yl)ethoxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate;but-2-enedioic acid

๐Ÿ“ Synonyms

5-[[2-(6-Amino-9H-purin-9-yl)ethoxy]methyl]-2,4,6,8-Tetraoxa-5-phosphanonanedioic Acid Bis(1-methylethyl) Ester 5-Oxide (2E)-2-Butenedioate; Desmethyl Tenofovir Disoproxoil Fumarate 1798422-29-3 NE687338AA 2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[2-(6-amino-9H-purin-9-yl)ethoxy]methyl]-, 1,9-bis(1-methylethyl) ester, 5-oxide, 2-butenedioate (1:1)

๐Ÿ”ฌ Chemical Identifiers

CC(C)OC(=O)OCOP(=O)(COCCN1C=NC2=C(N=CN=C21)N)OCOC(=O)OC(C)C.C(=CC(=O)O)C(=O)O
InChI=1S/C18H28N5O10P.C4H4O4/c1-12(2)32-17(24)28-9-30-34(26,31-10-29-18(25)33-13(3)4)11-27-6-5-23-8-22-14-15(19)20-7-21-16(14)23;5-3(6)1-2-4(7)8/h7-8,12-13H,5-6,9-11H2,1-4H3,(H2,19,20,21);1-2H,(H,5,6)(H,7,8)
ROFRIUDSSWUIQC-UHFFFAOYSA-N

Related Products